ClinConnect ClinConnect Logo
Search / Trial NCT05439200

Video Treatment for Amblyopia

Launched by RETINA FOUNDATION OF THE SOUTHWEST · Jun 27, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Asynchronous Movies for Amblyopia," is looking at whether watching special movies can help young children with amblyopia see better than the usual treatment, which involves wearing a patch over one eye. Amblyopia, sometimes known as "lazy eye," can happen when there is a big difference in vision between the two eyes. The researchers want to see if these movies can not only improve vision but also encourage children to stick to their treatment better.

Children aged 3 to 8 years old, both boys and girls, who have certain types of amblyopia and have been wearing glasses for at least 8 weeks are eligible for the trial. To join, their eye doctor and family must agree to try this new movie treatment instead of the traditional patching method. If your child participates, they will be asked to watch these movies as part of their treatment, and the study will monitor how their vision improves over time. This is an exciting opportunity to explore a different approach to treating amblyopia!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 3-8 years (3-7 primary cohort)
  • male and female
  • strabismic, anisometropic, or combined mechanism amblyopia (visual acuity 0.3-0.8 logMAR)
  • interocular visual acuity difference ≥0.3 logMAR
  • wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart
  • child's ophthalmologist and family willing to forgo standard patching treatment during the study
  • Exclusion Criteria:
  • prematurity ≥8 wk
  • coexisting ocular or systemic disease
  • developmental delay
  • strabismus \>5 pd
  • myopia \> -3.00D

About Retina Foundation Of The Southwest

The Retina Foundation of the Southwest is a leading clinical research organization dedicated to advancing the understanding and treatment of retinal diseases. With a focus on innovative therapies and cutting-edge research, the foundation collaborates with top-tier medical institutions and specialists to conduct rigorous clinical trials aimed at improving patient outcomes. Committed to excellence in patient care and scientific discovery, the Retina Foundation of the Southwest is at the forefront of developing novel interventions for conditions such as macular degeneration, diabetic retinopathy, and other vision-threatening disorders. Through its comprehensive approach, the foundation strives to enhance the quality of life for individuals affected by retinal diseases.

Locations

Dallas, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials